Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9405 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8966 |
High Similarity |
NPD7808 |
Phase 3 |
0.8908 |
High Similarity |
NPD7251 |
Discontinued |
0.8851 |
High Similarity |
NPD6797 |
Phase 2 |
0.8757 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8757 |
High Similarity |
NPD7075 |
Discontinued |
0.869 |
High Similarity |
NPD8455 |
Phase 2 |
0.8686 |
High Similarity |
NPD7472 |
Approved |
0.8629 |
High Similarity |
NPD7054 |
Approved |
0.8596 |
High Similarity |
NPD8312 |
Approved |
0.8596 |
High Similarity |
NPD8313 |
Approved |
0.858 |
High Similarity |
NPD7074 |
Phase 3 |
0.858 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8539 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD6801 |
Discontinued |
0.8457 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8457 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8427 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8391 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.838 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8372 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8246 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8225 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8214 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8196 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.815 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8107 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8103 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8103 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8046 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8031 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7968 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7929 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7912 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7901 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7879 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7846 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7846 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7846 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7833 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7833 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7809 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7806 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7806 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7798 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7784 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.776 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.768 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7663 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7654 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7644 |
Intermediate Similarity |
NPD1512 |
Approved |
0.764 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7638 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7633 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7624 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7596 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7585 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7574 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7529 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7526 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7487 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD919 |
Approved |
0.7457 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7457 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7437 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7407 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7401 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD920 |
Approved |
0.7396 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7366 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7293 |
Intermediate Similarity |
NPD37 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7288 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7288 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7268 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7263 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7251 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7249 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD1247 |
Approved |
0.72 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7193 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7193 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7129 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7128 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7121 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7121 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7101 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7069 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7052 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7049 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7029 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7029 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7029 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7022 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD1933 |
Approved |
0.699 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD2344 |
Approved |
0.6989 |
Remote Similarity |
NPD2346 |
Discontinued |
0.697 |
Remote Similarity |
NPD4287 |
Approved |
0.6966 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6927 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6927 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6927 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6927 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD3268 |
Approved |
0.691 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6895 |
Remote Similarity |
NPD5711 |
Approved |
0.6895 |
Remote Similarity |
NPD5710 |
Approved |
0.6882 |
Remote Similarity |
NPD2798 |
Approved |
0.6866 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6842 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6839 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD1613 |
Approved |
0.6836 |
Remote Similarity |
NPD6099 |
Approved |
0.6836 |
Remote Similarity |
NPD6100 |
Approved |
0.6833 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6833 |
Remote Similarity |
NPD2309 |
Approved |
0.6829 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD2797 |
Approved |
0.6824 |
Remote Similarity |
NPD1203 |
Approved |
0.6816 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6813 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6798
|
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |